Healthcare
NZX Listed Companies
Healthcare: revenue, EBITDA and net profit
Each company’s latest year whose income-statement figures passed the reconciliation checks behind the How They Make Money charts. Years differ between companies, so the year is shown beside every figure. Figures are extracted automatically from filed annual reports; check against the report.
Latest charted year by company (10 of 12 charted)
| Company | Revenue | EBITDA | EBITDA margin | Net profit | Net margin |
|---|---|---|---|---|---|
| FPHFisher & Paykel Healthcare Corporation Limited | $2.0b FY25 | $649.5m FY25 | 32.1% FY25 | $377.2m FY25 | 18.7% FY25 |
| EBOEBOS Group Limited | $12.3b FY25 | $555.6m FY25 | 4.5% FY25 | $215.8m FY25 | 1.8% FY25 |
| RYMRyman Healthcare Limited | $571.0m FY23 | $458.4m FY23 | 80.3% FY23 | $257.8m FY23 | 45.2% FY23 |
| SUMSummerset Group Holdings Limited | $361.8m FY25 | $299.5m FY25 | 82.8% FY25 | $259.7m FY25 | 71.8% FY25 |
| OCAOceania Healthcare Limited | $260.6m FY25 | $86.0m FY25 | 33.0% FY25 | $30.4m FY25 | 11.7% FY25 |
| AFTAFT Pharmaceuticals Limited | $254.7m FY26 | $28.8m FY26 | 11.3% FY26 | $14.1m FY26 | 5.5% FY26 |
| PEBPacific Edge Limited | Not charted: FY2026 (newest on file): Neither EBITDA nor EBIT is recorded, so operating profit cannot be placed. | ||||
| GXHGreen Cross Health Limited | $546.0m FY26 | $50.4m FY26 | 9.2% FY26 | $25.9m FY26 | 4.7% FY26 |
| RADRadius Residential Care Limited | $202.3m FY26 | $27.4m FY26 | 13.5% FY26 | $10.1m FY26 | 5.0% FY26 |
| PHLPromisia Healthcare Limited | $31.1m FY25 | $4.2m FY25 | 13.5% FY25 | $6.8m FY25 | 22.0% FY25 |
| RUARua Bioscience Limited | Not charted: FY2025 (newest on file): EBIT is -$3.3m. This layout does not draw an operating loss. | ||||
| BAIBeing AI | $40.5m FY24 | $3.0m FY24 | 7.3% FY24 | -$1.1m FY24 | -2.6% FY24 |
- RYM: newer FY2026 on file, not charted (no EBITDA/EBIT split).
- BAI: newer FY2026 on file, not charted (revenue ≤ 0).
EBITDA is the figure stored from each statement (or EBIT plus depreciation where only those are stored); “—” means the year has EBIT but no EBITDA. Companies that headline an adjusted measure (EBITDAF, underlying EBITDA) can report a different number.
EBITDA margin across the sector, by year
One dot per company-year that passed the checks, from FY2017; the bar is the median of those companies for that year. Years not charted are left out, not counted as zero.
one company-year sector median (needs two or more companies).
| Company | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| FPH | EBIT only | EBIT only | n/c: no EBITDA/EBIT split | EBIT only | n/c: no EBITDA/EBIT split | 34.3% | n/c: no EBITDA/EBIT split | 26.8% | 32.1% | no statement |
| EBO | no statement | 3.6% | 3.6% | 3.4% | EBIT only | 4.3% | 4.8% | 4.6% | 4.5% | no statement |
| RYM | n/c: profit exceeds revenue | n/c: profit exceeds revenue | 97.2% | 51.7% | n/c: profit exceeds revenue | n/c: profit exceeds revenue | 80.3% | n/c: not from annual report | n/c: operating loss | n/c: no EBITDA/EBIT split |
| SUM | n/c: not from annual report | n/c: not from annual report | n/c: no EBITDA/EBIT split | n/c: not from annual report | n/c: no EBITDA/EBIT split | n/c: no EBITDA/EBIT split | n/c: no EBITDA/EBIT split | n/c: profit exceeds revenue | 82.8% | no statement |
| OCA | 43.8% | 48.6% | 14.4% | n/c: unexplained residual | 32.0% | 33.0% | 32.4% | 31.1% | 33.0% | no statement |
| AFT | no statement | n/c: operating loss | EBIT only | EBIT only | EBIT only | n/c: not from annual report | n/c: not from annual report | 13.4% | 10.1% | 11.3% |
| PEB | no statement | no statement | n/c: not from annual report | no statement | n/c: not from annual report | no statement | n/c: not from annual report | n/c: not from annual report | n/c: no EBITDA/EBIT split | n/c: no EBITDA/EBIT split |
| GXH | n/c: not from annual report | n/c: not from annual report | 9.0% | 9.7% | 7.6% | 11.8% | 11.4% | 10.4% | 9.3% | 9.2% |
| RAD | no statement | 8.6% | n/c: not from annual report | 8.9% | 19.1% | n/c: operating loss | 9.7% | 12.2% | 13.2% | 13.5% |
| PHL | n/c: operating loss | n/c: operating loss | n/c: operating loss | no statement | 16.8% | 23.7% | 15.0% | 13.8% | 13.5% | no statement |
| RUA | no statement | no statement | no statement | no statement | n/c: no revenue | n/c: operating loss | n/c: operating loss | n/c: operating loss | n/c: operating loss | no statement |
| BAI | no statement | n/c: no revenue | n/c: revenue ≤ 0 | n/c: no EBITDA/EBIT split | no statement | n/c: no EBITDA/EBIT split | n/c: no EBITDA/EBIT split | 7.3% | n/c: no EBITDA/EBIT split | n/c: revenue ≤ 0 |
| Median (n) | — (1) | 8.6% (3) | 11.7% (4) | 9.3% (4) | 17.9% (4) | 23.7% (5) | 13.2% (6) | 12.8% (8) | 13.4% (8) | 11.3% (3) |
n/c = on file but not charted, with the reason (the full reason is on the company’s page). EBIT only = charted, but the year has no EBITDA to place here. Years are grouped by financial-year label; year-end months differ between companies.
All Companies in Healthcare
Frequently Asked Questions About NZX Healthcare Sector
What companies are in the NZX Healthcare sector?
The NZX Healthcare sector includes 12 listed companies with a combined market capitalization of approximately $37.6 billion. These companies represent New Zealand's publicly-traded businesses operating in healthcare industries.
How is the Healthcare sector performing?
The NZX Healthcare sector has an average 1-year return of +1.2%, based on the stock performance of companies within the sector. Individual company performance varies, and investors should review specific company metrics, governance scores, and financial statements before making investment decisions.
How do I compare companies in the Healthcare sector?
You can compare Healthcare companies on NZXplorer by reviewing key metrics including market capitalization, 1-year stock returns, governance risk scores (GRS), board independence, shareholder support levels, and financial performance. Each company page provides comprehensive governance data, director information, substantial shareholder analysis, and ESG metrics to help you make informed investment decisions.
What governance information is available for Healthcare companies?
NZXplorer provides comprehensive governance data for all NZX-listed Healthcare companies including: board composition and independence levels, director biographies and tenure, committee structures, director and executive remuneration, substantial shareholder holdings, AGM voting results and shareholder support scores, insider trading activity, and Governance Risk Scores (GRS v2.0) that evaluate executive remuneration, board structure, shareholder rights, board effectiveness, audit quality, and remuneration disclosure.
What is market capitalization and why does it matter?
Market capitalization (market cap) is the total value of a company's outstanding shares, calculated by multiplying the share price by the number of shares. It represents what the market believes the company is worth. The Healthcare sector has a combined market cap of $37.6 billion across 12 companies. Market cap helps investors understand company size and classify stocks as large-cap (typically >$1B), mid-cap ($300M-$1B), or small-cap (<$300M), with each category having different risk-return profiles and liquidity characteristics.
How can I track substantial shareholders in Healthcare companies?
NZXplorer tracks all substantial shareholder disclosures for Healthcare companies as required by NZX rules. Substantial shareholders are entities holding 5% or more of voting rights and must disclose their holdings publicly. You can view current substantial shareholders, their voting percentages, recent changes in holdings, and historical disclosure dates on each company's page. This information helps you understand ownership concentration, potential control dynamics, and significant stakeholder interests in Healthcare companies.